Highlights Grow & Deliver (compared with Q1 2021)
• Revenue up 12% and 10% higher in constant currencies, driven by strong pricing (up 17%)
• ROS at 9.1% (2021: 13.6%), resulting from continued raw material and freight costs inflation and
supply constraints
• Adjusted EBITDA at €317 million (2021: €391 million)
Highlights Q1 2022 (compared with Q1 2021)
• Pricing initiatives more than offset the increase of raw material and other variable costs (including
freight), which increased €334 million compared with Q1 2021. Volumes 7% lower
• Operating income at €232 million (2021: €303 million), includes €2 million net positive impact from
identified items (2021: €4 million net negative impact). OPI margin 9.2% (2021: 13.4%)
• Adjusted operating income at €230 million (2021: €307 million)
• Net cash from operating activities decreased to negative €102 million (2021: negative €31 million)
• Net income attributable to shareholders at €154 million (2021: €217 million)
• EPS from total operations at €0.87 (2021: €1.15); adjusted EPS from continuing operations at €0.86
(2021: €1.18)
Outlook
AkzoNobel targets to grow at or above its relevant markets, in line with the company’s Grow &
Deliver strategy. Trends differ per region and segment, with raw material and other variable cost
inflation (including freight) expected to gradually ease during the second half of 2022. AkzoNobel
aims to continue to offset raw material and other variable cost inflation (including freight) through
pricing initiatives. Market uncertainties have increased due to the sanctions on Russia and the resurgence of COVID-19 in China, among others. Assuming there are no further significant market disruptions, AkzoNobel aims to deliver the €2 billion adjusted EBITDA target for 2023, and an
average annual 50 basis points increase in return on sales over the period 2021-2023*. AkzoNobel targets a leverage ratio of 1-2 times net debt/EBITDA and is committed to retaining a strong investment grade credit rating.
* Please refer to the glossary on page 17 for underlying assumptions

see & read more on
https://www.akzonobel.com/content/dam/akzonobel-corporate/global/en/investor-relations-images/result-center/reports---presentation/2022---reports---presentations/q1-2022/report-q1-2022-akzonobel.pdf

tijd 11.34
Akzo Nobel EUR 82,82 +4,14 vol. 362.000